Article
Profiling B cell immune responses to identify neutralizing antibodies from convalescent COVID-19 patients
2020-08-12
Abstract excerpt
The pandemic Coronavirus Disease 2019 (COVID-19) causes noticeable morbidity and mortality worldwide. In addition to vaccine and antiviral drug therapy, the use of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) neutralizing antibodies for treatment purposes is a viable alternative. In this study, we aimed to profile the humoral responses and identify neutralizing antibodies against SARS-CoV-2 using h...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 93f2f03a-1a1a-509d-b602-d01c34c1773a
- DOI
- 10.21203/rs.3.rs-38173/v2
